H. Alejandro Preti

951 total citations
20 papers, 728 citations indexed

About

H. Alejandro Preti is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, H. Alejandro Preti has authored 20 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 9 papers in Genetics and 7 papers in Oncology. Recurrent topics in H. Alejandro Preti's work include Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Genetic factors in colorectal cancer (4 papers). H. Alejandro Preti is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Genetic factors in colorectal cancer (4 papers). H. Alejandro Preti collaborates with scholars based in United States, Australia and Colombia. H. Alejandro Preti's co-authors include Fernando Cabanillas, Peter McLaughlin, Jorge Romaguera, Fredrick B. Hagemeister, Anas Younes, William Pugh, Terry Smith, Armando López‐Guillermo, Andreas H. Sarris and Maria Alma Rodriguez and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

H. Alejandro Preti

19 papers receiving 716 citations

Peers

Countries citing papers authored by H. Alejandro Preti

Since Specialization

Citations

This map shows the geographic impact of H. Alejandro Preti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Alejandro Preti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Alejandro Preti more than expected).

Fields of papers citing papers by H. Alejandro Preti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Alejandro Preti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Alejandro Preti. The network helps show where H. Alejandro Preti may publish in the future.

Co-authorship network of co-authors of H. Alejandro Preti

This figure shows the co-authorship network connecting the top 25 collaborators of H. Alejandro Preti. A scholar is included among the top collaborators of H. Alejandro Preti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Alejandro Preti. H. Alejandro Preti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Unconventional Path to Healing 2019 ·SHILAP Revista de lepidopterología ·Shaden Khalaf, Mohammad Hussain, (unknown), H. Alejandro Preti, Mary R. Schwartz, Miguel Valderrábano, Faisal Nabi, Dipan J. Shah	0
2	Hypothalamic relapse of a cardiac large B-cell lymphoma presenting with memory loss, confabulation, alexia–agraphia, apathy, hypersomnia, appetite disturbances and diabetes insipidus 2018 ·BMJ Case Reports ·(unknown), Gustavo C. Román, Belén Pascual, Mary R. Schwartz, H. Alejandro Preti	6
3	Practical Pearls in Onco-Cardiology 2015 ·Methodist DeBakey Cardiovascular Journal ·H. Alejandro Preti	1
4	Prognostic impact of C-REL expression in diffuse large B-cell lymphoma 2009 ·Journal of Hematopathology ·Choladda V. Curry, (unknown), Randall J. Olsen, Brent R. Logan, H. Alejandro Preti, (unknown), Sherrie L. Perkins, Chung-Che Chang	20
5	Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition 2009 ·Leukemia Research ·Jianguo Wen, Yongdong Feng, Wan‐Ting Huang, Haiyun Chen, Bing Liao, Lawrence Rice, H. Alejandro Preti, Rammurti T. Kamble, Youli Zu, Douglas Ballon, Chung-Che Chang	41
6	Assessment of safety with abbreviated, weight-based bevacizumab infusions in a variety of solid tumors 2007 ·Journal of Clinical Oncology ·(unknown), (unknown), (unknown), H. Alejandro Preti	1
7	Atypical NK-cell Proliferation of the Gastrointestinal Tract in a Patient With Antigliadin Antibodies but not Celiac Disease 2006 ·The American Journal of Surgical Pathology ·Francisco Vega, Chung-Che Chang, Mary R. Schwartz, H. Alejandro Preti, Mamoun Younes, (unknown), Ray Verm, Elaine S. Jaffe	33
8	Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha 2005 ·Blood ·Peter McLaughlin, Elihu H. Estey, Armand B. Glassman, Jorge Romaguera, Felipe Samaniego, Ana Ayala, Kimberly Hayes, Anne Marie Maddox, H. Alejandro Preti, Fredrick B. Hagemeister	59
9	Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy 2003 ·Cancer ·Bouthaina S. Dabaja, Peter McLaughlin, Chul S. Ha, Barbara Pro, Christina A. Meyers, (unknown), Richard B. Wilder, Athanassios P. Kyritsis, H. Alejandro Preti, W.K. Alfred Yung, Victor A. Levin, Fernando Cabanillas, James D. Cox	19
10	Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin’s lymphoma 2001 ·Annals of Oncology ·Anas Younes, H. Alejandro Preti, Fredrick B. Hagemeister, Peter McLaughlin, Jorge Romaguera, Maria Alma Rodriguez, Barry I. Samuels, J. Lynn Palmer, Fernando Cabanillas	21
11	Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: Update of the MDACC series 2000 ·Annals of Oncology ·Armando López‐Guillermo, Fernando Cabanillas, Peter McLaughlin, Terry Smith, F. B. Hagemeister, Maria Alma Rodriguez, Jorge Romaguera, Anas Younes, A H Sarris, H. Alejandro Preti, William Pugh, (unknown)	42
12	Correlation of Bcl-2 Rearrangement With Clinical Characteristics and Outcome in Indolent Follicular Lymphoma 1999 ·Blood ·Armando López‐Guillermo, Fernando Cabanillas, Timothy McDonnell, Peter McLaughlin, Terry Smith, William Pugh, Fredrick B. Hagemeister, Maria Alma Rodriguez, Jorge Romaguera, Anas Younes, Andreas H. Sarris, H. Alejandro Preti, (unknown)	17
13	Correlation of Bcl-2 Rearrangement With Clinical Characteristics and Outcome in Indolent Follicular Lymphoma 1999 ·Blood ·Armando López‐Guillermo, Fernando Cabanillas, Timothy McDonnell, Peter McLaughlin, Terry Smith, William Pugh, Fredrick B. Hagemeister, Maria Alma Rodriguez, Jorge Romaguera, Anas Younes, Andreas H. Sarris, H. Alejandro Preti, (unknown)	114
14	Paclitaxel plus high‐dose cyclosphosphamide with G‐CSF support in patients with relapsed and refractory aggressive non‐Hodgkin's lymphoma 1998 ·British Journal of Haematology ·Anas Younes, Jorge Romaguera, (unknown), Frederick Hagemeister, Andreas H. Sarris, Maria Alma Rodriguez, Peter McLaughlin, H. Alejandro Preti, Carlos Bachier, Fernando Cabanillas	8
15	Ninety-Six-Hour Paclitaxel Infusion with Mitoxantrone and Ifosfamide/Mesna and Consolidation with ESHAP for Refractory and Relapsed Non-Hodgkin's Lymphoma 1998 ·Leukemia & lymphoma ·Jorge Romaguera, Fredrick B. Hagemeister, Peter McLaughlin, Maria Alma Rodriguez, Carlos Bachier, H. Alejandro Preti, A H Sarris, Damien C. Weber, Anas Younes, Fernando Cabanillas	3
16	The Clinical Significance of Molecular Response in Indolent Follicular Lymphomas 1998 ·Blood ·Armando López‐Guillermo, Fernando Cabanillas, Peter McLaughlin, Terry Smith, Fredrick B. Hagemeister, (unknown), Jorge Romaguera, Anas Younes, Andreas H. Sarris, H. Alejandro Preti, William Pugh, (unknown)	122
17	Prognostic Value of Serum Interleukin-6 in Diffuse Large-cell Lymphoma 1997 ·Annals of Internal Medicine ·H. Alejandro Preti, Fernando Cabanillas, Moshe Talpaz, Susan L. Tucker, John F. Seymour, Razelle Kurzrock	94
18	Myeloid markers in adult acute lymphocytic leukemia. Correlations with patient and disease characteristics and with prognosis 1995 ·Cancer ·H. Alejandro Preti, Yang O. Huh, Susan O’Brien, Michael Andreeff, Sherry Pierce, Michael J. Keating, Hagop M. Kantarjian	36
19	Philadelphia-chromosome-positive adult acute lymphocytic leukemia: Characteristics, treatment results, and prognosis in 41 patients 1994 ·The American Journal of Medicine ·H. Alejandro Preti, Susan O’Brien, Sergio Giralt, Miloslav Beran, (unknown), H. Kantarjian	90
20	Acute lymphocytic leukemia in adults: an update. 1994 ·PubMed ·H. Alejandro Preti, Hagop M. Kantarjian	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact